generic [phsu]
clopidogrel besylate [orch, phsu]
Secondary Prevention [topp]
Events [evnt]
month [tmco]
Follow-up [fndg]
Clinical [qlco]
Trial [resa]
Background [cnce]
Aim [idcn]
Present [qnco]
Interim [tmco]
Analysis [lbpr]
To [qlco]
Compare [acty]
Clinical [qlco]
Efficacy [qlco]
Safety [hcpp]
generic [phsu]
clopidogrel besylate [orch, phsu]
Clopidogrel hydrogen sulfate [orch, phsu]
Salt [chvs]
Group [idcn]
eligible [idcn]
Receive [qlco]
clopidogrel [orch, phsu]
Methods [inpr]
Arm [blor]
OPEN LABEL [resa]
Clinical Trial, Phase IV [inpr, resa]
Consecutive [qlco]
Patients [podg]
N NOS [aapp, imft]
screen [hlca]
Trial [resa]
randomized [resa]
Clopidogrel hydrogen sulfate [orch, phsu]
N NOS [aapp, imft]
clopidogrel besylate [orch, phsu]
N NOS [aapp, imft]
Primary Endpoint [irda]
Efficacy [qlco]
Composite [qlco]
Myocardial Infarction [dsyn]
Stroke [dsyn]
Death [orgf]
vascular [bpoc]
Primary Endpoint [irda]
Safety [hcpp]
Rate [acty]
Bleeding [patf]
Events [evnt]
Defined [cnce]
Bleeding [patf]
Academic [orgt]
Consortium [prog]
criteria [inpr]
Result [ftcn]
months [tmco]
Follow-up [fndg]
Observed [ftcn]
clopidogrel besylate [orch, phsu]
Clopidogrel hydrogen sulfate [orch, phsu]
Primary Endpoint [irda]
Efficacy [qlco]
P NOS [aapp, imft]
Rate [acty]
Bleeding [patf]
Academic [orgt]
Consortium [prog]
Bleeding [patf]
Similar [qlco]
Two [qnco]
Study [mnob]
Group [idcn]
Bleeding [patf]
Events [evnt]
Bleeding [patf]
Academic [orgt]
Consortium [prog]
Observed [ftcn]
Clopidogrel hydrogen sulfate [orch, phsu]
clopidogrel besylate [orch, phsu]
Group [idcn]
Conclusion [idcn]
Clinical [qlco]
Efficacy [qlco]
Safety [hcpp]
generic [phsu]
clopidogrel besylate [orch, phsu]
Similar [qlco]
Clopidogrel hydrogen sulfate [orch, phsu]
Salt [chvs]
generic [phsu]
clopidogrel [orch, phsu]
Formulation [resa]
Secondary Prevention [topp]
Events [evnt]
months [tmco]
Salts [chvs]
clopidogrel [orch, phsu]
Investigation [hlca]
Ensure [food]
Clinical Equivalency [qlco]
Science [ocdi]
Study [mnob]
Clinical Trials [resa]
GOV [gngm]
Identifier [inpr]
